David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains the use of combination therapy to extend duration of anti-androgen therapy response. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Use of Combination Therapy to Extend Duration of Anti-Androgen Therapy Response
